Albol-DS Chewable Tablet
Tablet
Drug International Ltd.Generic:
Almitrine Bismesylate + RaubasineWeight:
30 mg+10 mgbest Price:
৳ 12.00Generic
Almitrine Bismesylate + Raubasine
Pharmacology
Almitrine Bismesylate & Raubasine combines raubasine, a vasodilator; and almitrine, a respiratory stimulant. Raubasine has a adrenolytic activity which is predominantly related to a post-synaptic blocking effect. Furthermore, under conditions of cerebral hypoxia, almitrine causes an increase in the partial pressure of oxygen in arterial blood (Pa02); almitrine causes an increase in the Pa02 and an increase in the oxygen saturation in arterial blood (Sa02), without modifying ventilatory parameters.
Dosage Administration
1 tablet once or twice daily (taken separately, several hours apart), without exceeding 2 tablets per day. Or, as directed by the registered physicians.
Contraindications
This tablet is contraindicated in patients with hypersensitivity to any of the ingredients of it or severe hepatic impairment.
Side Effects
Weight loss, nausea, sensations of heaviness or burning in the stomach, gastrointestinal disorders, diarrhoea or constipation, insomnia, drowsiness, agitation, anxiety, dizziness, palpitations.
Pregnancy And Lactation
It is not recommended in pregnancy. It should be used with caution only when the expected benefit to the mother is greater than the possible risk to the fetus.
Therapeutic
Cerebral vasodilator & Neurosensory oxygenator drugs
Storage Conditions
Store at a cool and dry place, protected from light and moisture. Keep out of reach of children.